Coming out of the COVID-19 pandemic, public health can rebuild itself for the future. Our research aims to strengthen the public health infrastructure for future epidemics while supporting everyday practice.
Interim Director, Clem McDonald Center for Biomedical Informatics, Regenstrief Institute
Director of Public Health Informatics, Regenstrief Institute, Inc. and Indiana University Richard M. Fairbanks School of Public Health at IUPUI
Research Scientist, Clem McDonald Center for Biomedical Informatics, Regenstrief Institute
Research Scientist, William M. Tierney Center for Health Services Research, Regenstrief Institute
Associate Professor, Department of Epidemiology, Indiana University Richard M. Fairbanks School of Public Health at IUPUI
Affiliated Scientist, VA HSR&D Center for Health Information and Communication
Dr. Brian Dixon’s research focuses on applying informatics methods and tools to improve population and public health. His work leverages clinical and administrative data in electronic health records to measure population health, better understand the determinants of health, examine information flow in the health system, and improve outcomes in individuals and populations. Dr. Dixon also teaches informatics courses to future clinical and public health leaders.
Dr. Dixon is a Fellow within the prestigious American College of Medical Informatics (ACMI). He is also a Fellow of the American Medical Informatics Association (AMIA) and the Health Information Management Systems Society (HIMSS). In 2021, Dr. Dixon was part of a team of researchers whose work to support public health response to the COVID-19 pandemic was recognized by the Governor of Indiana as well as AcademyHealth with the Health Services Research (HSR) Impact Award. Previously, Dr. Dixon was named a Research Frontiers Trailblazer by IUPUI and recognized as a Forty Under 40 recipient by the Indianapolis Business Journal.
Dr. Dixon currently serves as Director of Public Health Informatics for Regenstrief Institute and IU Richard M. Fairbanks School of Public Health at IUPUI. He is co- principal investigator for a multi-year T15 grant funded by the US National Library of Medicine to mentor research scientists in public and population health informatics.
Dr. Dixon earned his Bachelor of Arts in computer science from DePauw University; his Master of Public Affairs from Indiana University; and his Doctor of Philosophy in Health Informatics from Indiana University.
Virtual Network to Investigate the Trajectory of COVID-19-Related Severe Outcomes
(CDC; PI: Grannis) (Jan 2021 – Aug 2022)
This study is a collaborative network of organizations led by the CDC and Westat that will leverage EHR and HIE data from 11 sites across the country to evaluate COVID-19 vaccine effectiveness. Regenstrief provides data on a bi-weekly basis to Westat, who will utilize these data and data from other sites to conduct a set of common analyses primarily focusing on vaccine effectiveness. In partnership with CDC and Westat, we will conduct additional analyses on subpopulations of interest as well as emerging trends related to COVID-19 vaccines.
Leveraging Electronic Health Data to Assess the Burden of Diabetes among Young Adults, part of Assessing the Burden of Diabetes By Type in Children, Adolescents and Young Adults (DiCAYA)
(CDC) (Sep 2020 – Sep 2025)
Role: Co-Principal Investigator
We will leverage an electronic health data network, representative of its underlying population, to better estimate incidence and prevalence of diabetes. The long-term objective of this project is to enhance access to information that can stimulate improving the surveillance, prevention, and management of diabetes across Indiana and the nation.
Improving Chronic Disease Surveillance and Management through the Use of EHRs and Health Information Systems (MENDS)
(National Association of Chronic Disease Directors/Centers for Disease Control and Prevention) (Aug 2020 – Jul 2023)
Role: Site PI
We will leverage an electronic health data network, representative of its underlying population, to estimate incidence and prevalence of hypertension and other chronic diseases. Surveillance data will be shared with clinical and public health partners to inform disease management as well as primary and secondary prevention strategies at the community level.
Estimating Gonorrhea and Chlamydia Treatment Rates in US Private Settings
(CDC) (Oct 2021 – Sep 2022)
Role: Principal Investigator
Using evidence from real-world administrative and clinical information systems, we will assess the percentage of patients with diagnosed gonorrhea (GC) or chlamydia (CT) who are treated with the recommended treatments in private settings.
Clinical Informatics Study Guide: Text and Review. 2 ed.
Publication: Zurich: Springer International Publishing